Capital Research (HAL) files 13G/A showing 1.0% stake in Halliburton
Rhea-AI Filing Summary
Halliburton Co. received an amendment to a Schedule 13G/A from Capital Research Global Investors reporting beneficial ownership of 8,651,999 shares, equal to 1.0% of the 835,397,735 shares believed to be outstanding.
The filing lists sole voting power of 8,651,990 and sole dispositive power of 8,651,999. The amendment is dated 06/30/2026 and signed on 07/01/2026.
Positive
- None.
Negative
- None.
Insights
Large investment manager reports a 1.0% position in Halliburton.
Capital Research Global Investors discloses ownership of 8,651,999 shares, representing 1.0% of the company's shares outstanding (stated as 835,397,735 shares). The filing specifies sole voting and dispositive powers for nearly all reported shares.
This is a passive ownership disclosure under a Schedule 13G/A amendment; cash‑flow treatment and plans for disposition are not stated in the excerpt. Subsequent filings or press releases would be required to reveal any trading intentions.
Key Figures
Key Terms
Schedule 13G/A regulatory
beneficial owner regulatory
sole dispositive power regulatory
CUSIP market
FAQ
What stake does Capital Research Global Investors report in HAL?
What date does the Schedule 13G/A amendment reference for HAL?
Who signed the Schedule 13G/A amendment for HAL?
Is this ownership above the 5% Schedule 13D threshold for HAL?
AI-generated analysis. How Rhea-AI works. Not financial advice.